Ci-Ca Masterclass
Join us for insightful events focused on advancing patient care and innovation in dialysis treatment.
Think Ci-Ca Therapy
Your responsibility in good hands
What is Regional Citrate
Anticoagulation (RCA)?
This video describes how RCA helps to reduce treatment downtime of CKRT
Why RCA?
The RICH trial demonstrates that RCA enables patient treatment with fewer bleeding complications and less filter clotting compared to heparin CKRT 1-3. Access our publication summary to learn more. The RICH trial demonstrates that RCA enables patient treatment with fewer bleeding complications and less filter clotting compared to heparin CKRT 1-3. Access our publication summary to learn more.
Our Offer
Hear directly from patients who have experienced the benefits of HDF firsthand. Learn about the positive outcomes and real-life impacts of this therapy in their lives. Discover how this therapy has improved their lives through positive outcomes and meaningful real-world impacts.
Join Us on Friday, February 7th at WCN 2025
Hear from leading nephrologists from India and around the world, with a special presentation by a patient currently benefiting from HDF therapy. Don't miss these insightful perspectives on the future of nephrology and a pragmatic approach on how to implement HDF in your clinic.
Get your invite